A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

The Lancet

Volumn 385, Issue 9962, 2015, Pages 43-54

  Serruys, Patrick W ^a   Chevalier, Bernard ^b   Dudek, Dariusz ^c   Cequier, Angel ^d   Carrié, Didier ^e   Iniguez, Andres ^f   Dominici, Marcello ^g   Van Der Schaaf, René J ^h   Haude, Michael ⁱ   Wasungu, Luc ^j   Veldhof, Susan ^j   Peng, Lei ^j   Staehr, Peter ^j   Grundeken, Maik J ^k   Ishibashi, Yuki ^l   Garcia Garcia, Hector M ^l,m   Onuma, Yoshinobu ^l,m  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Institut Jacques Cartier   (France)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e CHU RANGUEIL   (France)

^f HOSPITAL DO MEIXOEIRO   (Spain)

^g Department of Medical Oncology   (Italy)

^h ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

ⁱ Lukaskrankenhaus GmbH   (Germany)

^j ABBOTT VASCULAR   (United States)

^k ACADEMIC MEDICAL CENTER   (Netherlands)

^l ERASMUS MEDICAL CENTER   (Netherlands)

^m CARDIALYSIS   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; NITRATE; BIOMATERIAL; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON DILATATION; BIORESORBABLE SCAFFOLD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DIABETES MELLITUS; DRUG ELUTING STENT; EVEROLIMUS ELUTING BIORESORBABLE SCAFFOLD; EVEROLIMUS ELUTING METALLIC STENT; EXERCISE TEST; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVASCULAR ULTRASOUND; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METAL STENT; MULTICENTER STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; ADOLESCENT; ANALOGS AND DERIVATIVES; BIODEGRADABLE IMPLANT; CLINICAL TRIAL; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; QUESTIONNAIRE; TISSUE SCAFFOLD; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ABSORBABLE IMPLANTS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOCOMPATIBLE MATERIALS; CORONARY ANGIOGRAPHY; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SINGLE-BLIND METHOD; SIROLIMUS; TISSUE SCAFFOLDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84920439758     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)61455-0     Document Type: Article

References (36)

1. G Nakazawa, F Otsuka, M Nakano et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents J Am Coll Cardiol 57 2011 1314 1322
2. J Daemen, P Wenaweser, K Tsuchida et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
3. S Brugaletta, BD Gogas, HM Garcia-Garcia et al. Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments Circ J 76 2012 1616 1623
4. JP Lane, LE Perkins, AJ Sheehy et al. Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries JACC Cardiovasc Interv 7 2014 688 695
5. PW Serruys, HM Garcia-Garcia, Y Onuma From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 33 2012 16 25b
6. JA Ormiston, PW Serruys, E Regar et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial Lancet 371 2008 899 907
7. PW Serruys, JA Ormiston, Y Onuma et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910
8. PW Serruys, Y Onuma, JA Ormiston et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes Circulation 122 2010 2301 2312
9. PW Serruys, Y Onuma, D Dudek et al. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes J Am Coll Cardiol 58 2011 1578 1588
10. JA Ormiston, PW Serruys, Y Onuma et al. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study Circ Cardiovasc Interv 5 2012 620 632
11. PW Serruys, Y Onuma, HM Garcia-Garcia et al. Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months EuroIntervention 9 2014 1271 1284
12. Y Onuma, PW Serruys, J Gomez et al. Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent Catheter Cardiovasc Interv 78 2011 3 12
13. PW Serruys, HE Luijten, KJ Beatt et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months Circulation 77 1988 361 371
14. Y Onuma, PW Serruys, LE Perkins et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial Circulation 122 2010 2288 2300
15. CV Bourantas, MI Papafaklis, L Lakkas et al. Fusion of optical coherence tomographic and angiographic data for more accurate evaluation of the endothelial shear stress patterns and neointimal distribution after bioresorbable scaffold implantation: comparison with intravascular ultrasound-derived reconstructions Int J Cardiovasc Imag 30 2014 485 494
16. R Diletti, PW Serruys, V Farooq et al. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design Am Heart J 164 2012 654 663
17. M Task Force, G Montalescot, U Sechtem et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology Eur Heart J 34 2013 2949 3003
18. EI Skalidis, PE Vardas Guidelines on the management of stable angina pectoris Eur Heart J 27 2006 2606 author reply -7.
19. JA Spertus, JA Winder, TA Dewhurst et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease J Am Coll Cardiol 25 1995 333 341
20. WE Boden, RA O'Rourke, KK Teo et al. Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
21. RJ Gibbons, GJ Balady, JT Bricker et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines) Circulation 106 2002 1883 1892
22. TJ Ryan, DP Faxon, RM Gunnar et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty) Circulation 78 1988 486 502
23. J Gomez-Lara, S Brugaletta, V Farooq et al. Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up JACC Cardiovasc Interv 4 2011 789 799
24. J Gomez-Lara, HM Garcia-Garcia, Y Onuma et al. A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents JACC Cardiovasc Interv 3 2010 1190 1198
25. S Tanimoto, PW Serruys, L Thuesen et al. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials Catheter Cardiovasc Interv 70 2007 515 523
26. Y Onuma, PW Serruys, JA Ormiston et al. Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial EuroIntervention 6 2010 447 453
27. JA Ormiston, F De Vroey, PW Serruys, MW Webster Bioresorbable polymeric vascular scaffolds: a cautionary tale Circ Cardiovasc Interv 4 2011 535 538
28. A Mattesini, M Pighi, N Konstantidinis et al. Optical coherence tomography in bioabsorbable stents: mechanism of vascular response and guidance of stent implantation Minerva Cardioangiol 62 2014 71 82
29. AJ Brown, LM McCormick, DM Braganza, MR Bennett, SP Hoole, NE West Expansion and malapposition characteristics after bioresorbable vascular scaffold implantation Catheter Cardiovasc Interv 84 2014 37 45
30. J Herrmann Peri-procedural myocardial injury: 2005 update Eur Heart J 26 2005 2493 2519
31. DW Park, YH Kim, SC Yun et al. Impact of the angiographic mechanisms underlying periprocedural myocardial infarction after drug-eluting stent implantation Am J Cardiol 113 2014 1105 1110
32. ID Moussa, LW Klein, B Shah et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI) J Am Coll Cardiol 62 2013 1563 1570
33. K Thygesen, JS Alpert, AS Jaffe et al. Third universal definition of myocardial infarction Eur Heart J 33 2012 2551 2567
34. JB Lindsey, SP Marso, M Pencina et al. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry JACC Cardiovasc Interv 2 2009 1074 1082
35. CC O'Brien, VB Kolachalama, TJ Barber, A Simmons, ER Edelman Impact of flow pulsatility on arterial drug distribution in stent-based therapy J Control Release 168 2013 115 124
36. CV Bourantas, MI Papafaklis, A Kotsia et al. Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study JACC Cardiovasc Interv 7 2014 315 324